Pfizer
Sirsij Peshin is an accomplished professional with extensive experience in procurement and commercial operations within the pharmaceutical industry, primarily at Pfizer since June 2003, where key roles include Chief Procurement Officer and Vice President of Global Commercial Operations. Responsibilities encompass driving HCP and patient engagement programs, as well as overseeing various operational areas such as multi-channel management and incentive compensation for significant revenue-generating regions like Japan. Prior experience includes strategic roles at Pharmacia & Upjohn, Max India Ltd, Ballarpur Industries Ltd, and New International Travels. Sirsij holds a Master's in Computer Applications from Thapar Institute of Engineering & Technology, coupled with management development training from prestigious institutions such as the Indian Institute of Management Ahmedabad and Macquarie University.
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.